TFS
BIO icon

TrustCore Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

TrustCore Financial Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8
Closed -$4K – 1057
2022
Q2 		$4K Hold
8
– – ﹤0.01% 868
2022
Q1 		$5K Hold
8
– – ﹤0.01% 844
2021
Q4 		$6K Sell
8
-65
-89% -$48.6K ﹤0.01% 761
2021
Q3 		$54K Buy
73
+65
+813% +$48.7K 0.01% 449
2021
Q2 		$5K Buy
+8
New +$4.87K ﹤0.01% 830

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TrustCore Financial Services's BIO Position: Q3 2022 in Review

TrustCore Financial Services sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 8 shares — an estimated $4K sold.

TrustCore Financial Services first reported a position in BIO in Q2 2021 and held it in 5 quarters. The position peaked at $54K in Q3 2021. 486 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

  • TrustCore Financial Services reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
  • TrustCore Financial Services sold 8 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $4K.
  • TrustCore Financial Services first reported a position in Bio-Rad Laboratories Class A in Q2 2021 and held it in 5 quarters.
  • TrustCore Financial Services's Bio-Rad Laboratories Class A position peaked at $54K in Q3 2021.
  • 486 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on TrustCore Financial Services's 13F filing for Q3 2022, filed 3 Nov 2022.